Sylvain M. Jereme's most recent trade in Dexcom Inc was a trade of 12,001 Common Stock done at an average price of $70.4 . Disclosure was reported to the exchange on March 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Sale of securities on an exchange or to another person at price $ 70.38 per share. | 12 Mar 2025 | 12,001 | 123,481 (0%) | 0% | 70.4 | 844,632 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 35,906 | 119,684 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 22,798 | 142,482 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Sale of securities on an exchange or to another person at price $ 74.04 per share. | 08 Mar 2025 | 3,203 | 136,609 (0%) | 0% | 74.0 | 237,151 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Sale of securities on an exchange or to another person at price $ 73.22 per share. | 08 Mar 2025 | 2,670 | 139,812 (0%) | 0% | 73.2 | 195,489 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Sale of securities on an exchange or to another person at price $ 74.70 per share. | 08 Mar 2025 | 1,127 | 135,482 (0%) | 0% | 74.7 | 84,189 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 5,586 | 85,616 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Sale of securities on an exchange or to another person at price $ 86.91 per share. | 28 Jan 2025 | 2,090 | 83,526 (0%) | 0% | 86.9 | 181,650 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Sale of securities on an exchange or to another person at price $ 76.87 per share. | 16 Dec 2024 | 744 | 80,030 (0%) | 0% | 76.9 | 57,191 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Sale of securities on an exchange or to another person at price $ 75.51 per share. | 15 Nov 2024 | 3,500 | 80,774 (0%) | 0% | 75.5 | 264,285 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financal Officer | Sale of securities on an exchange or to another person at price $ 69.15 per share. | 09 Sep 2024 | 746 | 84,274 (0%) | 0% | 69.2 | 51,586 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 115.05 per share. | 10 Jun 2024 | 745 | 84,948 (0%) | 0% | 115.1 | 85,713 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 134.41 per share. | 12 Mar 2024 | 11,661 | 85,534 (0%) | 0% | 134.4 | 1,567,363 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 26,053 | 97,195 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | M. Jereme Sylvain | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 116.73 per share. | 20 Feb 2024 | 3,363 | 71,142 (0%) | 0% | 116.7 | 392,563 | Common Stock |
| Dexcom Inc | Jereme Sylvain M. | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 7,171 | 77,239 (0%) | 0% | 0.0 | 7 | Common Stock |
| Dexcom Inc | M. Jereme Sylvain | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 123.63 per share. | 12 Jan 2024 | 2,734 | 74,505 (0%) | 0% | 123.6 | 338,018 | Common Stock |
| Dexcom Inc | Sylvain M. Jereme | EVP Chief Financial Officer | Sale or transfer of securities back to the company at price $ 121.85 per share. | 18 Dec 2023 | 2,932 | 70,068 (0%) | 0% | 121.8 | 357,261 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 104.38 per share. | 22 Aug 2023 | 1,844 | 72,867 (0%) | 0% | 104.4 | 192,477 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 117.58 per share. | 22 May 2023 | 2,400 | 74,711 (0%) | 0% | 117.6 | 282,192 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 3,604 | 79,751 (0%) | 0% | 111.4 | 401,482 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 3,374 | 83,355 (0%) | 0% | 111.4 | 375,860 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 1,857 | 77,894 (0%) | 0% | 111.4 | 206,868 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 783 | 77,111 (0%) | 0% | 111.4 | 87,225 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 21,769 | 86,729 (0%) | 0% | 0.0 | 22 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 114.54 per share. | 22 Feb 2023 | 2,400 | 64,837 (0%) | 0% | 114.5 | 274,896 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 112.62 per share. | 21 Nov 2022 | 2,400 | 67,237 (0%) | 0% | 112.6 | 270,288 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 301.57 per share. | 06 Jun 2022 | 600 | 17,408 (0%) | 0% | 301.6 | 180,942 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 5,297 | 19,959 (0%) | 0% | 0.0 | 5 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 844 | 18,624 (0%) | 0% | 406.1 | 342,712 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 491 | 19,468 (0%) | 0% | 406.1 | 199,374 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 424 | 18,200 (0%) | 0% | 406.1 | 172,168 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 192 | 18,008 (0%) | 0% | 406.1 | 77,963 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 2,925 | 15,217 (0%) | 0% | 0.0 | 3 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 517.59 per share. | 06 Dec 2021 | 600 | 12,292 (0%) | 0% | 517.6 | 310,554 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 634.12 per share. | 09 Nov 2021 | 634 | 12,892 (0%) | 0% | 634.1 | 402,032 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 541.36 per share. | 09 Sep 2021 | 402 | 13,531 (0%) | 0% | 541.4 | 217,627 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 541.80 per share. | 09 Sep 2021 | 5 | 13,526 (0%) | 0% | 541.8 | 2,709 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 545.41 per share. | 07 Sep 2021 | 587 | 13,933 (0%) | 0% | 545.4 | 320,156 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 346.74 per share. | 24 May 2021 | 600 | 14,508 (0%) | 0% | 346.7 | 208,044 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 362.92 per share. | 10 Mar 2021 | 941 | 15,108 (0%) | 0% | 362.9 | 341,505 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | SVP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 5,301 | 16,049 (0%) | 0% | 0.0 | 5 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 404.00 per share. | 24 Feb 2021 | 600 | 10,700 (0%) | 0% | 404 | 242,400 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 320.37 per share. | 24 Nov 2020 | 600 | 11,300 (0%) | 0% | 320.4 | 192,222 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 336.22 per share. | 10 Nov 2020 | 632 | 11,900 (0%) | 0% | 336.2 | 212,491 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 398.30 per share. | 09 Sep 2020 | 289 | 12,532 (0%) | 0% | 398.3 | 115,109 | Common Stock |
| Dexcom Inc | Jereme M. Sylvain | SVP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 427.41 per share. | 24 Aug 2020 | 600 | 12,817 (0%) | 0% | 427.4 | 256,446 | Common Stock |